GSK and MMV present positive data on treatment for Plasmodium vivax malaria in children from 6 months up to 15 years of age 19 Nov 2020
Event Highlights from the VivAccess Hosted Symposium at Virtual ASTMH: Accelerating New Tools for Radical Cure of Vivax Malaria from Clinical and Operational Research to Policy 18 Nov 2020
Thailand becomes first malaria-endemic country in Asia-Pacific to approve tafenoquine for radical cure of P. vivax malaria 24 Apr 2020
Solicitud de propuesta - Desarrollo de comprimidos de dosis baja de primaquina en una formulación adaptada a los niños 08 Jan 2020
Country leaders pledge to boost malaria innovation and access to new and existing antimalarials 11 Nov 2019
Brazil becomes first malaria-endemic country to approve single-dose tafenoquine (Kozenis) for radical cure of P. vivax malaria 31 Oct 2019
Expert Review Panel for Diagnostics approval expands access to a G6PD deficiency test that supports P. vivax malaria treatment and elimination initiatives 03 Oct 2019
29 May 2024 2024 Geneva Health Forum This year's GHF will focus on health and the environment with a day dedicated to the elimination of malaria. 27 - 29 May 2024 Geneva, Switzerland
12 Feb 2025 9th International Conference on Plasmodium vivax Research (ICPvR) 2025 The 9th International Conference on Plasmodium vivaxResearch will take place in Puducherry, India from 12th to 14th February 2025. 12 - 14 Feb 2025 Puducherry, India